New precision tool aims to improve liver cancer ablation

NCT ID NCT05361551

Recruiting now Disease control Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new, more precise way to perform liver ablation (using heat or cold to destroy tumors) in people with liver cancer. The technique combines stereotactic guidance, special CT imaging, and computer software to ensure the entire tumor is treated. About 50 participants with up to 5 small liver metastases will be enrolled to see if this approach improves treatment accuracy and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: liver ablation procedure
What this could lead to: If successful, this could make liver tumor ablation more precise and effective, potentially reducing the need for repeat procedures.
What could go wrong: This is a small, early-phase trial with only 50 participants, so results may not apply to everyone. The technique is complex and may not improve outcomes significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATIC LIVER ABLATION

Contacts and locations

Locations

M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.